EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies

Michael Piepenbrink, Fatai Oladunni, Aitor Nogales, Ahmed M Khalil, Theresa Fitzgerald, Madhubanti Basu, Christopher Fucile, David J Topham iD, Alexander F Rosenberg, Luis Martinez-Sobrido iD, James J Kobie iD

Microbiology Spectrum · 2023

DOI: 10.1128/spectrum.04728-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2023. Verfasst von Michael Piepenbrink und 10 weiteren Autor:innen. Beteiligte Einrichtung: Heersink School of Medicine, Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines, Influenza A Virus, H1N1 Subtype, Influenza A virus. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, HHS | National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza A virus (IAV) infections continue to cause substantial morbidity and mortality despite the availability of seasonal vaccines. The extensive genetic variability in seasonal and potentially pandemic influenza strains necessitates new vaccine strategies that can induce universal protection by focusing the immune response on generating protective antibodies against conserved targets within the influenza virus hemagglutinin and neuraminidase proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza VaccinesInfluenza A Virus, H1N1 SubtypeInfluenza A virusHumansAnimalsMiceHemagglutininsInfluenza A Virus, H3N2 SubtypeNeuraminidaseAntibodies, MonoclonalAntibodies, ViralHemagglutinin Glycoproteins, Influenza Virus

Stichwörter der Autor:innen

B cell responseshemagglutininimmunizationinfluenzamonoclonal antibodiesneuraminidaseneutralizing antibodies

Substanzen

Influenza VaccinesHemagglutininsNeuraminidaseAntibodies, MonoclonalAntibodies, ViralHemagglutinin Glycoproteins, Influenza Virus

Autor:innen und Institutionen

  • Heersink School of Medicine, Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama, USA.
  • Department of Medicine, Infectious Diseases Division, University of Rochester, Rochester, New York, USA.
  • Texas Biomedical Research Institute, San Antonio, Texas, USA.
  • Department of Microbiology and Immunology, University of Rochester Medical Center, School of Medicine and Dentistry, Rochester, New York, USA.
  • Department of Zoonotic Diseases, Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt.
  • Heersink School of Medicine, Informatics Institute, University of Alabama at Birmingham, Birmingham, Alabama, USA.

ORCID-Profile: David J Topham, Luis Martinez-Sobrido, James J Kobie

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • HHS | National Institutes of Health

Zitieren

APA

Piepenbrink, M., Oladunni, F., Nogales, A., Khalil, A. M., Fitzgerald, T., Basu, M., Fucile, C., Topham, D. J., Rosenberg, A. F., Martinez-Sobrido, L., & Kobie, J. J. (2023). Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies. Microbiology Spectrum. https://doi.org/10.1128/spectrum.04728-22

Vancouver

Piepenbrink M, Oladunni F, Nogales A, Khalil AM, Fitzgerald T, Basu M, et al. Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies. Microbiology Spectrum. 2023. doi:10.1128/spectrum.04728-22

BibTeX
@article{Piepenbrink2023,
  author = {Piepenbrink, Michael and Oladunni, Fatai and Nogales, Aitor and Khalil, Ahmed M and Fitzgerald, Theresa and Basu, Madhubanti and Fucile, Christopher and Topham, David J and Rosenberg, Alexander F and Martinez-Sobrido, Luis and Kobie, James J},
  title = {Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies},
  journal = {Microbiology Spectrum},
  year = {2023},
  doi = {10.1128/spectrum.04728-22}
}
Kostenlos starten →